News
-
-
COMMUNIQUÉ DE PRESSE
BRAIN Biotech reports its 9M results and continues to target a break-even adjusted Group-EBITDA
BRAIN Biotech reports 9M results targeting break-even adjusted Group-EBITDA. BRAINBioIncubator forecast raised, BRAINBiocatalysts lowered. Detailed financial data and outlook included -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: BRAIN Biotech AG Appoints Dr. Sven K. Weber as New Chairman of the Executive Board, Effective October 1, 2026
BRAIN Biotech AG appoints Dr. Sven K. Weber as new Chairman of the Executive Board, effective October 1, 2026. Dr. Weber, with experience at BASF SE, replaces Adriaan Moelker -
-